Cellular Pharmacokinetics and Pharmacodynamics of the Glycopeptide Antibiotic Oritavancin (LY333328) in a Model of J774 Mouse Macrophages

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2004-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.48.8.2853-2860.2004PMID 15273091PMCID PMC478544
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glycopeptide Antibiotics

  2012cited by this paper
• Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.

  2004cited by this paper
• Intracellular accumulation and activity of ampicillin used as free drug and as its phthalimidomethyl or pivaloyloxymethyl ester (pivampicillin) against Listeria monocytogenes in J774 macrophages.

  2003cited by this paper
• PROTEIN DEGRADATION IN CULTURED CELLS II. The Uptake of Chloroquine by Rat Fibroblasts and the Inhibition of Cellular Protein Degradation and Cathepsin Bx

  2003cited by this paper
• Quantitative Analysis of Gentamicin, Azithromycin, Telithromycin, Ciprofloxacin, Moxifloxacin, and Oritavancin (LY333328) Activities against Intracellular Staphylococcus aureus in Mouse J774 Macrophages

  2003cited by this paper
• Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus.

  2003cited by this paper
• Cell Handling, Membrane-Binding Properties and Membrane-Penetration Modeling Approaches of Pivampicillin and Phthalimidomethylampicillin, Two Basic Esters of Ampicillin, in Comparison with Chloroquine and Azithromycin

  2003cited by this paper
• Influence of P-Glycoprotein Inhibitors on Accumulation of Macrolides in J774 Murine Macrophages

  2003cited by this paper
• Azithromycin, a lysosomotropic antibiotic, has distinct effects on fluid-phase and receptor-mediated endocytosis, but does not impair phagocytosis in J774 macrophages.

  2002cited by this paper
• Azithromycin, a lysosomotropic antibiotic, impairs fluid-phase pinocytosis in cultured fibroblasts.

  2001cited by this paper
• Uptake and intracellular activity of ofloxacin isomers in human phagocytic and non-phagocytic cells.

  2000cited by this paper
• Gentamicin-induced apoptosis in renal cell lines and embryonic rat fibroblasts.

  2000cited by this paper
• Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models.

  1999cited by this paper
• Endocytosis of gentamicin in a proximal tubular renal cell line.

  1999cited by this paper
• Modulation of intracellular growth of Listeria monocytogenes in human enterocyte Caco-2 cells by interferon-gamma and interleukin-6: role of nitric oxide and cooperation with antibiotics.

  1999cited by this paper
• Mechanism of the Intracellular Killing and Modulation of Antibiotic Susceptibility of Listeria monocytogenes in THP-1 Macrophages Activated by Gamma Interferon

  1999cited by this paper
• In Vitro Studies of Pharmacodynamic Properties of Vancomycin against Staphylococcus aureus andStaphylococcus epidermidis

  1998cited by this paper
• Comparison of Inhibitory and Bactericidal Activities and Postantibiotic Effects of LY333328 and Ampicillin Used Singly and in Combination against Vancomycin-Resistant Enterococcus faecium

  1998cited by this paper
• Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.

  1998cited by this paper
• Beyond vancomycin: new therapies to meet the challenge of glycopeptide resistance.

  1997cited by this paper
• Endocytosis.

  1997cited by this paper
• Reductive alkylation of glycopeptide antibiotics: synthesis and antibacterial activity.

  1996cited by this paper
• Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic

  1996cited by this paper
• The glycopeptide story--how to kill the deadly 'superbugs'.

  1996cited by this paper
• Accumulation, release and subcellular localization of azithromycin in phagocytic and non-phagocytic cells in culture.

  1994cited by this paper
• Clathrin polymerization is not required for bulk-phase endocytosis in rat fetal fibroblasts

  1994cited by this paper
• Cellular transport of drugs.

  1994cited by this paper
• Subcellular localization of tobramycin and vancomycin given alone and in combination in proximal tubular cells, determined by immunogold labeling

  1992cited by this paper
• Cellular uptake, and intracellular bactericidal activity of teicoplanin in human macrophages.

  1989cited by this paper
• Intraphagocytic penetration of antibiotics.

  1988cited by this paper
• Biological characterization and oncogene expression in human colorectal carcinoma cell lines

  1988cited by this paper
• High teicoplanin uptake by human neutrophils.

  1988cited by this paper
• Influence of conversion of penicillin G into a basic derivative on its accumulation and subcellular localization in cultured macrophages

  1987cited by this paper
• Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells.

  1987cited by this paper
• Suppression of penicillin-induced bacteriolysis of staphylococci by some anticoagulants.

  1987cited by this paper
• Automated fluorescence polarization immunoassay for monitoring vancomycin.

  1983cited by this paper
• Perturbation of vesicular traffic with the carboxylic ionophore monensin.

  1983cited by this paper
• Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1)

  1980cited by this paper
• Properties of Wilms' tumor line (TuWi) and pig kidney line (LLC-PK1) typical of normal kidney tubular epithelium

  1979cited by this paper
• Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents.

  1978cited by this paper
• The uptake and intracellular accumulation of aminoglycoside antibiotics in lysosomes of cultured rat fibroblasts.

  1978cited by this paper
• Biologic and biochemical activities of continuous macrophage cell lines P388D1 and J774.1.

  1977cited by this paper
• Endocytosis.

  1977cited by this paper
• PROTEIN DEGRADATION IN CULTURED CELLS

  1974cited by this paper
• Commentary. Lysosomotropic agents.

  1974cited by this paper
• PINOCYTOSIS IN FIBROBLASTS

  1974cited by this paper
• ANALYTICAL FRACTIONATION OF HOMOGENATES FROM CULTURED RAT EMBRYO FIBROBLASTS

  1974cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Antibacterial Activity of Zinc-Doped Hydroxyapatite and Vancomycin-Loaded Gelatin Nanoparticles against Intracellular Staphylococcus aureus in Human THP-1 Derived Macrophages

  2024cites this paper
• Dual-targeted poly(amino acid) nanoparticles deliver drug combinations on-site: an intracellular synergistic strategy to eliminate intracellular bacteria.

  2023cites this paper
• Emergence and Mechanism of Resistance of Tulathromycin Against Mycoplasma hyopneumoniae in a PK/PD Model and the Fitness Costs of 23S rRNA Mutants

  2022cites this paper
• Nanocarriers for the delivery of antibiotics into cells against intracellular bacterial infection.

  2022cites this paper
• Strategies to Overcome Biological Barriers Associated with Pulmonary Drug Delivery

  2022cites this paper
• Pharmacokinetic/Pharmacodynamic Modeling of Spiramycin against Mycoplasma synoviae in Chickens

  2021cites this paper
• Long-Acting Lipoglycopeptides for the Treatment of Bone and Joint Infections

  2021cites this paper
• Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections

  2021cites this paper
• Current and future options for treating complicated skin and soft tissue infections: focus on fluoroquinolones and long-acting lipoglycopeptide antibiotics

  2021cites this paper
• Evaluation of intraosteoblastic activity of dalbavancin against Staphylococcus aureus in an ex vivo model of bone cell infection.

  2021cites this paper
• Influence of pH on the activity of finafloxacin against extracellular and intracellular Burkholderia thailandensis, Yersinia pseudotuberculosis, and Francisella philomiragia and on its cellular pharmacokinetics in THP-1 monocytes.

  2020cites this paper
• The PK/PD Integration and Resistance of Tilmicosin against Mycoplasma hyopneumoniae

  2020cites this paper
• Pharmacokinetic and Pharmacodynamic Integration and Resistance Analysis of Tilmicosin Against Mycoplasma gallisepticum in an In Vitro Dynamic Model

  2019cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other Glycopeptides

  2018cites this paper
• Cellular Pharmacokinetics and Intracellular Activity of Gepotidacin against Staphylococcus aureus Isolates with Different Resistance Phenotypes in Models of Cultured Phagocytic Cells

  2018cites this paper
• A Cell-Penetrating Peptide Fused Phage Lysin Kills Intracellular MRSA 1 in Keratinocytes and Treatment for Skin Infections of Mice 2

  2018cites this paper
• A Phage Lysin Fused to a Cell-Penetrating Peptide Kills Intracellular Methicillin-Resistant Staphylococcus aureus in Keratinocytes and Has Potential as a Treatment for Skin Infections in Mice

  2018cites this paper
• Oritavancin: a long-acting antibacterial lipoglycopeptide.

  2016cites this paper
• From Natural Products to Drugs: Glyco- and Lipoglycopeptides, a New Generation of Potent Cell Wall Biosynthesis Inhibitors

  2016cites this paper
• Antibiotic Drug Delivery Systems for the Intracellular Targeting of Bacterial Pathogens

  2016cites this paper
• Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review

  2015cites this paper
• Naturally Occurring Peptides from Rana temporaria: Antimicrobial Properties and More.

  2015cites this paper
• Cellular Pharmacokinetics and Intracellular Activity of the Novel Peptide Deformylase Inhibitor GSK1322322 against Staphylococcus aureus Laboratory and Clinical Strains with Various Resistance Phenotypes: Studies with Human THP-1 Monocytes and J774 Murine Macrophages

  2015cites this paper
• Oritavancin for the treatment of acute bacterial skin and skin structure infections: an evidence-based review

  2015cites this paper
• Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis

  2015cites this paper
• Oritavancin: A Review in Acute Bacterial Skin and Skin Structure Infections

  2015cites this paper
• Chemistry and biology of glycopeptides with antibiotic activity.

  2014cites this paper
• The Design of Novel Nano-Sized Polyanion-Polycation Complexes for Oral Protein Delivery

  2014cites this paper
• Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones

  2014cites this paper
• Temporins A and B Stimulate Migration of HaCaT Keratinocytes and Kill Intracellular Staphylococcus aureus

  2014cites this paper
• Accumulation Lipoglycopeptide with High Cellular Cells Exposed to Oritavancin , a J 774 Cells and Human Activated THP-1 Study of Macrophage Functions in Murine

  2014cites this paper
• Study of Macrophage Functions in Murine J774 Cells and Human Activated THP-1 Cells Exposed to Oritavancin, a Lipoglycopeptide with High Cellular Accumulation

  2014cites this paper
• Tissue Colonization in Biomaterial-Associated Infection

  2013cites this paper
• Oritavancin - a new semisynthetic lipoglycopeptide agent to tackle the challenge of resistant gram positive pathogens.

  2013cites this paper
• Novel avenues for Clostridium difficile infection drug discovery

  2013cites this paper
• Biomaterials Associated Infection: Immunological Aspects and Antimicrobial Strategies

  2013cites this paper
• In vivo activity of oritavancin in animal infection models and rationale for a new dosing regimen in humans.

  2012cites this paper
• Glycopeptides and Lipoglycopeptides

  2012cites this paper
• Pharmacokinetics-pharmacology disconnection of herbal medicines and its potential solutions with cellular pharmacokinetic-pharmacodynamic strategy.

  2012cites this paper
• Macrophage killing of bacterial and fungal pathogens is not inhibited by intense intracellular accumulation of the lipoglycopeptide antibiotic oritavancin.

  2012cites this paper
• Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin.

  2012cites this paper
• The cellular pharmacokinetics of HIV protease inhibitors: current knowledge and future perspectives.

  2012cites this paper
• Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin

  2012cites this paper
• Toward a new age of cellular pharmacokinetics in drug discovery

  2011cites this paper
• Expression, regulation and functional activities of aminopeptidase N (EC 3.4.11.2; APN; CD13) on murine macrophage J774 cell line.

  2011cites this paper
• Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint.

  2011cites this paper
• Cheminformatic and Mechanistic Study of Drug Subcellular Transport/Distribution.

  2011cites this paper
• Cellular Pharmacokinetics of the Novel Biaryloxazolidinone Radezolid in Phagocytic Cells: Studies with Macrophages and Polymorphonuclear Neutrophils

  2010cites this paper
• Oritavancin: a novel lipoglycopeptide active against Gram-positive pathogens including multiresistant strains.

  2010cites this paper
• Intra- and Extracellular Activities of Dicloxacillin against Staphylococcus aureus In Vivo and In Vitro

  2010cites this paper
• Unique Aspects of Content Unique Aspects of Software

  2010cites this paper
• Cellular Pharmacodynamics of the Novel Biaryloxazolidinone Radezolid: Studies with Infected Phagocytic and Nonphagocytic cells, Using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila

  2010cites this paper
• Intra- and extracellular activity of linezolid against Staphylococcus aureus in vivo and in vitro.

  2010cites this paper
• Intracellular Activity of Antibiotics in a Model of Human THP-1 Macrophages Infected by a Staphylococcus aureus Small-Colony Variant Strain Isolated from a Cystic Fibrosis Patient: Study of Antibiotic Combinations

  2009cites this paper
• Intracellular Activity of Antibiotics in a Model of Human THP-1 Macrophages Infected by a Staphylococcus aureus Small-Colony Variant Strain Isolated from a Cystic Fibrosis Patient: Pharmacodynamic Evaluation and Comparison with Isogenic Normal-Phenotype and Revertant Strains

  2009cites this paper
• Intracellular Activity of Antibiotics against Staphylococcus aureus in a Mouse Peritonitis Model

  2009cites this paper
• New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus.

  2009cites this paper
• New antimicrobials on the horizon

  2009cites this paper
• Oritavancin for skin infections.

  2008cites this paper
• New and Investigational Antimicrobials for the Treatment of Severe Skin Infections

  2008cites this paper
• Cyclic Lipopeptide Antibiotics

  2008cites this paper
• Comparison of the In Vitro Efficacies of Moxifloxacin and Amoxicillin against Listeria monocytogenes

  2008cites this paper
• New antimicrobial agents for the treatment of Gram-positive bacterial infections.

  2008cites this paper
• Oritavancin: a new promising agent in the treatment of infections due to Gram-positive pathogens

  2008cites this paper
• Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.

  2008cites this paper
• Efficacy of Oritavancin in a Murine Model of Bacillus anthracis Spore Inhalation Anthrax

  2008cites this paper
• The bacterial envelope as a target for novel anti-MRSA antibiotics.

  2008cites this paper
• Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts)

  2008influential citation
• COMPARISON BETWEEN THE IN VITRO EFFICACY OF MOXIFLOXACIN AND AMOXICILLIN AGAINST LISTERIA MONOCYTOGENES

  2008cites this paper
• Pharmacodynamic Evaluation of the Intracellular Activities of Antibiotics against Staphylococcus aureus in a Model of THP-1 Macrophages

  2006cites this paper
• Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.

  2006cites this paper
• Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives.

  2006cites this paper
• Oritavancin – an investigational glycopeptide antibiotic

  2006influential citation
• Glycopeptides and glycodepsipeptides in clinical development: a comparative review of their antibacterial spectrum, pharmacokinetics and clinical efficacy.

  2006cites this paper
• Evaluation of the extracellular and intracellular activities ( human THP-1 macrophages ) of telavancin versus vancomycin against methicillin-susceptible , methicillin-resistant , vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus

  2006cites this paper
• Apport de l’expérimentation au traitement des infections graves par les cocci à gram positif : corrélations in vitro – in vivo

  2005cites this paper
• Changes in endosome-lysosome pH accompanying pre-malignant transformation.

  2005cites this paper
• Antibiotic accumulation and efflux in eukaryotic cells : a journey at the frontier of pharmacokinetics and pharmacodynamics/

  2005influential citation
• Mixed-Lipid Storage Disorder Induced in Macrophages and Fibroblasts by Oritavancin (LY333328), a New Glycopeptide Antibiotic with Exceptional Cellular Accumulation

  2005cites this paper
• Antimicrobial agents : bacterial / fungal Non typhoid salmonellosis : the Israeli experience and review of the literature 563

  2005cites this paper
• Oritavancin: a new avenue for resistant Gram-positive bacteria

  2005cites this paper
• Glycopeptides in clinical development: pharmacological profile and clinical perspectives.

  2004cites this paper